BACKGROUND: Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. METHODS: Data from a nationally representative sample of US adults were used to compare concordance of past-year DSM-IV opioid, cannabis, cocaine and alcohol dependence with past-year DSM-5 disorders at thresholds of 3+, 4+, 5+ and 6+ positive DSM-5 criteria among past-year users of opioids (n=264), cannabis (n=1622), cocaine (n=271) and alcohol (n=23,013). Substance-specific 2 × 2 tables yielded overall concordance (kappa), sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV). RESULTS: For DSM-IV alcohol, cocaine and opioid dependence, optimal concordance occurred when 4+ DSM-5 criteria were endorsed, corresponding to the threshold for moderate DSM-5 alcohol, cocaine and opioid use disorders. Maximal concordance of DSM-IV cannabis dependence and DSM-5 cannabis use disorder occurred when 6+ criteria were endorsed, corresponding to the threshold for severe DSM-5 cannabis use disorder. At these optimal thresholds, sensitivity, specificity, PPV and NPV generally exceeded 85% (>75% for cannabis). CONCLUSIONS: Overall, excellent correspondence of DSM-IV dependence with DSM-5 substance use disorders was documented in this general population sample of alcohol, cannabis, cocaine and opioid users. Applicability of treatments tested for DSM-IV dependence is supported by these results for those with a DSM-5 alcohol, cocaine or opioid use disorder of at least moderate severity or severe cannabis use disorder. Further research is needed to provide evidence for applicability of treatments for persons with milder substance use disorders. Published by Elsevier Ireland Ltd.
BACKGROUND: Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. METHODS: Data from a nationally representative sample of US adults were used to compare concordance of past-year DSM-IV opioid, cannabis, cocaine and alcohol dependence with past-year DSM-5 disorders at thresholds of 3+, 4+, 5+ and 6+ positive DSM-5 criteria among past-year users of opioids (n=264), cannabis (n=1622), cocaine (n=271) and alcohol (n=23,013). Substance-specific 2 × 2 tables yielded overall concordance (kappa), sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV). RESULTS: For DSM-IV alcohol, cocaine and opioid dependence, optimal concordance occurred when 4+ DSM-5 criteria were endorsed, corresponding to the threshold for moderate DSM-5 alcohol, cocaine and opioid use disorders. Maximal concordance of DSM-IV cannabis dependence and DSM-5 cannabis use disorder occurred when 6+ criteria were endorsed, corresponding to the threshold for severe DSM-5 cannabis use disorder. At these optimal thresholds, sensitivity, specificity, PPV and NPV generally exceeded 85% (>75% for cannabis). CONCLUSIONS: Overall, excellent correspondence of DSM-IV dependence with DSM-5 substance use disorders was documented in this general population sample of alcohol, cannabis, cocaine and opioid users. Applicability of treatments tested for DSM-IV dependence is supported by these results for those with a DSM-5 alcohol, cocaine or opioid use disorder of at least moderate severity or severe cannabis use disorder. Further research is needed to provide evidence for applicability of treatments for persons with milder substance use disorders. Published by Elsevier Ireland Ltd.
Entities:
Keywords:
Concordance; DSM-5; DSM-IV; Diagnosis; Kappa; Substance use disorder
Authors: Deborah A Dawson; Sharon M Smith; Tulshi D Saha; Anna D Rubinsky; Bridget F Grant Journal: Drug Alcohol Depend Date: 2012-06-22 Impact factor: 4.492
Authors: Charles A Dackis; Kyle M Kampman; Kevin G Lynch; Jennifer G Plebani; Helen M Pettinati; Thorne Sparkman; Charles P O'Brien Journal: J Subst Abuse Treat Date: 2012-02-27
Authors: Ziva D Cooper; Richard W Foltin; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Margaret Haney Journal: Addict Biol Date: 2012-06-28 Impact factor: 4.280
Authors: Ashley P Kennedy; Robin E Gross; Natasha Whitfield; Karen P G Drexler; Clinton D Kilts Journal: Addict Behav Date: 2012-03-13 Impact factor: 3.913
Authors: Risë B Goldstein; S Patricia Chou; Sharon M Smith; Jeesun Jung; Haitao Zhang; Tulshi D Saha; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant Journal: J Stud Alcohol Drugs Date: 2015-05 Impact factor: 2.582
Authors: Alex J Brewer; David A Nielsen; Catherine J Spellicy; Sara C Hamon; Justin Gingrich; Daisy G Y Thompson-Lake; Ellen M Nielsen; James J Mahoney; Thomas R Kosten; Thomas F Newton; Richard De La Garza Journal: Pharmacogenet Genomics Date: 2015-06 Impact factor: 2.089
Authors: Kathryn Hawk; Gail D'Onofrio; David A Fiellin; Marek C Chawarski; Patrick G O'Connor; Patricia H Owens; Michael V Pantalon; Steven L Bernstein Journal: Acad Emerg Med Date: 2017-12-26 Impact factor: 3.451